EMEA-000631-PIP01-09
Key facts
| Active substance |
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/235/2009
|
| PIP number |
EMEA-000631-PIP01-09
|
| Pharmaceutical form(s) |
Capsule, hard
|
| Condition(s) / indication(s) |
Prevention of Ischaemic Heart Disease
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Ferrer Internacional, S.A
E-mail: jrandreu@ferrergrupo.com / silviamartin@ferrergrupo.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|